In this episode of Idea Collider, host Mike Rea interviews Paul Peter Tak, CEO of Candel Therapeutics, discussing his remarkable journey from a clinician in Amsterdam to leading cutting-edge biotech companies. Paul shares pivotal moments in his career, the challenges of transitioning from academia to big pharma, and the innovative principles he applied. He dives deep into Candel’s promising work in viral immunotherapies for cancers and the unique leadership and management philosophies that have guided his journey. Additionally, Paul Peter touches on his passion for leveraging collective intelligence and his unconventional hobbies that keep him grounded and creative.
00:00 Introduction and Guest Welcome
00:59 Early Career and Passion for Medicine
02:09 Transition to Industry and GSK Experience
04:50 Building Successful Organizations
07:42 Innovative Models in Pharma
19:03 Joining Candel Therapeutics and Vision for the Future
25:15 Transforming Cancer Treatment
27:24 Challenges in Biotech Market
28:45 Strategic Decisions and Prioritization
31:39 Collaborations and External Partnerships
33:07 Innovative Approaches and Future Prospects
44:23 Leadership and Personal Insights
Don't forget to Like, Share, Subscribe, Rate, and Review!
Keep up with Paul Peter Tak;
LinkedIn: https://www.linkedin.com/in/paul-peter-tak-md-phd-fmedsci-1b44749/
Follow Mike Rea On;
Website: https://www.ideapharma.com/
LinkedIn: https://www.linkedin.com/in/bigidea/
Listen to more fantastic podcast episodes: https://podcast.ideapharma.com/